Botulinum toxin improves forehead scars after Mohs surgery: A randomized, double-blinded, controlled study

J Am Acad Dermatol. 2022 Apr;86(4):964-966. doi: 10.1016/j.jaad.2021.03.110. Epub 2021 Apr 10.

Authors

Matthew J Lin¹, Daniel M Bernstein², Richard L Torbeck², Danielle P Dubin², Joshua D Rosenberg³, Hooman Khorasani²

Affiliations

¹ Division of Dermatologic Surgery, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: matthew.lin@mountsinai.org.
² Division of Dermatologic Surgery, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Division of Facial Plastic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 33848604
DOI: 10.1016/j.jaad.2021.03.110

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Botulinum Toxins, Type A* / therapeutic use
Cicatrix / etiology
Cicatrix / prevention & control
Double-Blind Method
Forehead / surgery
Humans
Mohs Surgery / adverse effects
Neuromuscular Agents* / therapeutic use
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A